This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Babu, M Articles by Oliver, N Search for Related Content PubMed PubMed Citation Articles by Babu, M Articles by Oliver, N

Fibronectin is overproduced by keloid fibroblasts during abnormal wound healing.

Department of Anatomy and Cell Biology, Tufts University Health Sciences Campus, Boston, Massachusetts 02111.

ABSTRACT

Wound healing in certain individuals leads to the development of keloid tumors which exhibit abnormal collagen metabolism and an increased abundance of extracellular matrix components. Comparison of fibronectin levels in fibroblasts derived from keloids and normal dermis revealed a relative increase in intracellular and extracellular fibronectin in the keloid-derived cells. While fibronectin was similarly processed, compartmentalized, and degraded by both cell types, fibronectin biosynthesis was found to be accelerated as much as fourfold in keloid fibroblasts due to a corresponding increase in the amount of accumulated fibronectin mRNA. These changes account for the elevated steady-state level of the molecule in keloid fibroblasts and suggest that increased fibronectin in keloid lesions is due to overproduction by the wound-healing fibroblasts. Glucocorticoid treatment stimulated fibronectin biosynthesis in both normal and keloid fibroblasts. However, the amount of stimulation was less for the keloid-derived cells, indicating a limitation on maximal rates of fibronectin biosynthesis. These observations suggest that separate mechanisms act to control basal and maximal rates of fibronectin production. Biosynthesis of the 140-kilodalton fibronectin receptor was also found to be increased in keloid fibroblasts, suggesting some level of coordinate regulation for fibronectin and fibronectin receptor expression.

This article has been cited by other articles:

• Torkian, B. A., Yeh, A. T., Engel, R., Sun, C.-H., Tromberg, B. J., Wong, B. J. F. (2004). Modeling Aberrant Wound Healing Using Tissue-Engineered Skin Constructs and Multiphoton Microscopy. Arch Facial Plast Surg 6: 180-187 [Abstract] [Full Text]  
• Wu, Y., Zhang, Q., Ann, D. K., Akhondzadeh, A., Duong, H. S., Messadi, D. V., Le, A. D. (2004). Increased vascular endothelial growth factor may account for elevated level of plasminogen activator inhibitor-1 via activating ERK1/2 in keloid fibroblasts. Am. J. Physiol. Cell Physiol. 286: C905-C912 [Abstract] [Full Text]  
• Tuan, T.-L., Wu, H., Huang, E. Y., Chong, S. S. N., Laug, W., Messadi, D., Kelly, P., Le, A. (2003). Increased Plasminogen Activator Inhibitor-1 in Keloid Fibroblasts May Account for their Elevated Collagen Accumulation in Fibrin Gel Cultures. Am. J. Pathol. 162: 1579-1589 [Abstract] [Full Text]  
• McCormack, M. C., Nowak, K. C., Koch, R. J. (2001). The Effect of Copper Tripeptide and Tretinoin on Growth Factor Production in a Serum-Free Fibroblast Model. Arch Facial Plast Surg 3: 28-32 [Abstract] [Full Text]  
• Dustan, H. P. (1995). Does Keloid Pathogenesis Hold the Key to Understanding Black/White Differences in Hypertension Severity?. Hypertension 26: 858-862 [Abstract] [Full Text]